Isodiol International Inc. adds Andrew S. Alvis to its Board of Directors and appointed Chairman of Audit Committee
May 13, 2020 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F)(the “Company” or “Isodiol”), today announces the addition of its current President, Andrew Stanton Alvis, to its growing Board of Directors and appointed Chairman of the Audit Committee.
Mr. Alvis brings to Isodiol and its board of directors his extensive experience in all aspects of leadership, strategy, operational efficiency, and revenue growth. Mr. Alvis possesses a background that spans across multiple industries, with an overall vast knowledge of foreign finance and accounting, including audit and compliance processes. During his time with Attila Management as Chief Financial Officer, Toyota Financial Services, as National Manager, Data Strategy Executive and Bank of America as SVP, Senior Finance Executive, he has proven success in driving organizational change to achieve profitable growth while maintaining expenses through creative business solutions.
Alvis sees his appointment to the board as a great opportunity: “I’m excited to be a member of an Isodiol board focused on growth and expansion while ensuring all appropriate business and financial controls are implemented and audited accordingly. I look forward to continuing to help the company move forward in my additional capacity as a board member.”
Isodiol International Inc. continues to add key components and various industry experts like Mr. Alvis to bolster its efforts in becoming a true leader in the innovation-focused manufacturing and distribution of CBD related products.
“We are proud to have Mr. Alvis join the Board of Directors for Isodiol International Inc. We are confident that his previous experience and business acumen will help continue to add value to the company.” Agramont continues with “Mr. Alvis will be instrumental in restructuring the organization to meet both customer and shareholder expectations by driving efficient operations & scalable revenue opportunities by focusing on adding value to the bottom line of the company.
About Isodiol International Inc.
Follow Our Corporate Updates On Facebook at www.facebook.com/IsodiolInternationalInc/,
on Twitter @Isodiolintlinc, and on Instagram @isodiol.
About Isodiol International Inc.
Isodiol International Inc. is focused on the nutritional health benefits that are derived from hemp and is a product development, sales, marketing and distribution company of hemp-based Consumer Packaged Goods (CPG) and solutions. Isodiol has commercialized a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nanotechnology for quality consumable and topical skincare products. Isodiol’s growth strategy includes the development of over-the counter and pharmaceutical drugs and continued international expansion into Latin America, Asia, and Europe.
ON BEHALF OF THE BOARD
Marcos Agramont, CEO & Director
INVESTOR RELATIONS:
[email protected]
604-409-4409
MEDIA CONTACT:
[email protected]
The CSE has not reviewed, approved or disapproved the content of this press release.
Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, proposed arrangement with creditors, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend, to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release.